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1048-90 Pregnancy Associated Plasma Protein-A Levels Are 
Elevated in Patients With Unstable Angina 
Ali E. Denktas, Patricia J. M. Best, Julie Woodrum, Michael T. Overgaard, Michael 
Christiansen, Claus Oxvig, David R. Holmes, Jr., Cheryl A. Conover, Amir Lerman. Mayo 
Clinic. Rochester, MN, University of Aarhus, Aarhus, Denmark 
Background: Pregnancy-associated plasma protein A (PAPP-A), recently identified as 
an insulin like growth factor (IGF) bmding protein proteinase, IS a high molecular weight 
zinc blnding metalloproteinase secreted by vascular smooth muscle cells. Increased 
PAPP-A activity leads to enhanced IGF bioactivity and may contribute to the progression 
of atherosclerosis. Thus, the current study was designed to test the hypothesis that circu- 
lating PAPP-A levels are elevated in patients (pts) with unstable angina (UA). Methods: 
Blood samples were taken from 333 pts undergoing cardiac catheterization at the Mayo 
Clinic. PAPP-A levels were analyzed using a biotin-tyramids-amplified enzyme immu- 
noassay. UA was defined as the new onset of angina1 symptoms (~6 weeks), rest paIn, 
or post infarction angina (within 3 weeks of Infarction). Control pts were those who had 
coronary disease and did not meet the requirements for UA or were undergoing routine 
cardiac catheterization for preoperative cardiac surgery such as valve repairfreplace- 
ment. ThIrtytwo pts with UA were identified and the circulating levels of PAPP-A were 
compared to the remaining pts. Clinical characteristics were identified through patlent 
interview and chart review. Coronary angiograms were reviewed for the extent of the dis- 
ease, which was defined as the number of major vessels with >70% stenosis. Results: 
The study group consisted of 333 pts, 223 (67%) were males, mean age 64+11. There 
were no differences in the age, gender, presence of diabetes, hypertension, family his- 
tory, cholesterol levels, smoking hastory of the pts with or without UA. The PAPP-A levels 
in the UA pts ware significantly higher than in the pts without VA (7.1 * 4.0 vs. 5.5 * 3.4 
mlU/L, p= 0.01, two sided p=O.O36). PAPP-A levels were associated with older age 
(pcO.OOl), male gender (p&005) and lower levels of high-density lipoprotein (p=O.OOZ). 
PAPP-A levels were not associated with the extent of the coronary artery disease. Con- 
clusion: Patients with unstable angina have higher levels of circulating PAPP-A than 
patients without unstable angina. PAPP-A may be marker for plaque instability. 
1048-91 Elevated C-Reactive Protein Levels Are Associated With 
Myocardial lschemia Early in the Course of Non-ST 
Elevation Coronary Syndromes 
Olaa Papadaki, Michael N Zairis. John A. Ambrose, Marla Thoma, Paraskevi 
Psarogianm, Stavros Manousakis, Olga Ampartzidou. Alexander Kardoulas, Mary 
DeVoe, Kostas Katsaros, Kostas Karidis, Stefanos Foussas. Tzanlo Hospital, Piraeus. 
Greece, The Comprehensive Cardiovascular Center, St. Vincent Catholic Medical 
Center, New York, NY 
Background High plasma levels of C-reactive protein (CRP) are associated with short- 
or long-term ischemic complications in patients with unstable coronary artery disease. 
However, a possible direct relationship of plasma CRP with spontaneous myocardial 
&hernia early I” the course of non ST elevation acute coronary syndromes (NSTACS) 
was not thoroughly investigated. 
MethodsTo evaluate this issue 172 consecutive patients with NSTACS with no elevated 
plasma cardiac troponin T levels upon admission (cTnT-zO.1 yojdl) who underwent a 24 
hour continuous IBlead electrocardiographic (ECG) monitoring were studied. The asso- 
ciatlon of plasma CRP levels upon admission with either the incidence or duration of the 
recorded myocardial ischemla (ST-segment shifts) was evaluated. Patients divided into 
three groups according to the tertiles of CRP values upon admission. 
Results During 3,696 hours of contmuous 12.lead ECG monitoring, 169 ST-segment 
shifts were recorded in 48 patients with a mean number of 3.5k2.0 shifts per patient and 
a mean duration of 29.6i23.6 min per episode, corresponding to a total duration of 
124.4k143.6 mm per patlent. There was a significant gradual increased risk for either the 
incidence (p<O.OOl) or the total duration of ST-segment shifts with increasing of CRP ter- 
tiles (p=O.Ol). MultivarIate analysis showed that CRP tertiles were independently and 
positively related to the occurrence of ST-segment shifts. 
Conclusions High plasma levels of CRP may be associated with a higher incidence of 
myocardial tschemia early III the tours.? of NSTACS, suggesting a direct relationship of 
inflammation in this process. 
1048-92 Coronary Expression of Heat Shock Protein 60 and 
Serum Antibody Levels in Patients With Acute Coronary 
Syndrome 
Rvu Shutta. Shiro Hoshida, Tamaki Itakura, Shmichiro Suna, Masayuki Taniike. 
Yasuyuki Egami. Kenjiro Tanaka, Takayoshi Adachi, Masami Nishino, Hideo Tanahashi, 
Jun Tanouchi, Yoshlo Yamada, Osaka Rosa1 Hospital, Osaka, Japan, Yao City Hospital, 
Osaka. Japan 
Background- The production of heat shock protein (HSP) in coronary arteries provokes 
an autoimmune reaction with the anti-HSP antibody. We examined the relation between 
the instability of ischemlc heart disease (IHD) and inflammatory cell Infiltration and HSP 
expression in coronary tissues as well as the serum levels of HSP antibody. Methods 
and Result+ Coronary specimens from 73 symptomatic patients (acute coronary syn- 
drome [ACS, n=33]; stable IHD, 1x40) who had undergone a coronary atherectomy were 
immunohistochemicallv tested for the exoression of human and chlamvdial HSPGO. 
HSP70, CD66 (macrophages) and CD3 (T lymphocytes). Specimens from ACS patients 
exhibited a sianificantlv broader area of stainina for CD66. CD3. and chlamvdial and - . 
human HSPGO, compared with stable IHD patients (8.4&6% vs 2.9r0.4%. 4.2+0.3% vs 
2.OiO 3%, 6.0*0.4% vs 2.4iO.3%, p<O.OOl, respectively, 11.3+0.9% v.s 7.7+0.7%, 
p<O.O05). A discriminant function analysis revealed that the expression of CD66 plus 
chlamydial and human HSPGO in the same lesions could clearly differentiate coronary 
specimens from ACS patients and specimens from stable IHD patients (accuracy 86.3%, 
F-value. 33.82). When blood samples were obtained from ACS patients (n=54) and sta- 
ble IHD patients (n=520), the levels of a&human HSPGO antibodies were significantly 
higher in ACS patients than in stable IHD patients (0.606~0.022 vs. 0.757+0.010, 
~~0.05). Conclusions- The coexistence of inflammatory cells and HSPGO associated 
with elevated serum levels of HSPGO antibodies may be related to the etiologic mecha- 
nisms of unstable plaque. 
1048-93 Coagulation Activation and Long-Term Outcome in 
Acute Coronary Syndromes 
Piera Anaelica Merlini, Kenneth A. Bauer, Diego Ardissino, Robert Rosenberg, Ospedale 
Niguarda, Milan, Italy 
Rationale. After an episode of unstable angina or myocardlal infarction, a high propor- 
tion of patients show biochemical signs of coagulation activation, expressed as persis- 
tently elevated thrombin generation, in their blood. It is not known whether this has any 
influence on long-term outcome. 
Objective. In this prospective multicenter cohort study we assessed the relation of per- 
sistently elevated thrombin generation to outcome in patients with acute coronary syn- 
dromes. A total of 319 consecutive patients with acute coronary syndromes enrolled in 
GUSTO Ilb trial.. Plasma prothrombin fragment I+2 levels, an index of ?n VIVO” thrombin 
generation, was measured during the acute phase and after one, six and 12 months, and 
Its relation to outcome was assessed during a median 29.month follow-up. 
Findings The primary end-point of cardiac death or myocardial (re)infarction occurred in 
61 patients (19%). There was a U-shaped relation between plasma prothrombin frag- 
ment It2 tevels and the risk of developing the primary end-point: Intermediate levels 
(1.5-l .9 nmoVL) were associated with the lowest risk, whereas both htgher (> 1.9 nmollL) 
and lower (cl .5 nmol/L) values were associated with an increased risk (RR 1.56, 95% 
confidence Interval 1.25-2.28; RR 1.35; 95% confidence intawal 1.1 l-1.66; respec- 
tively)Conclusions After an episode of acute coronary syndrome, both high and low lev- 
els of thrombin generation are predictors of an increased risk of an unfavourable 
outcome. 
1048-94 IL-6 Genotypic Polymorphism and IL-6 Levels in Acute 
Coronary Syndromes With and Without ST-Segment 
Elevation 
Athanassios Manainas Evgenia Bei, Nektarios Pilatis. Antigoni Chaidaroglou. Dlmitris 
Degiannis, Ekaterini Koniavitou, Dennis V. Cokkinos, Onassis Cardiac Surgery Center, 
Athens, Greece 
Background: Inflammation plays an important role in the pathogen&s of acute coronary 
syndromes (ACS) with ST-segment elevation (STSE) and without ST-segment elevation 
(NSTSE). Interleukin-6 (IL6) is an inflammatory marker with prognostic value in patients 
with coronary artery disease (CAD) and is elevated in ACS. 
Methods: We studied 66 consecutwe patients (aged 61*11 years, 56 males) admitted to 
our institution with ACS. Forty-seven patients (aged 63&, 39 males) presented with 
NSTSE and 21 (aged 57*15, 19 males) with STSE ACS. Clinical, electrocardiographic 
and laboratory parameters were recorded. Genotypic analysis of IL6 gene polymorphism 
G/C-174 was performed with the PCR-SSP technique. Quantitative assessment of 
serum IL6 levels was performed on a blood sample drawn within 46 hours from the last 
episode of chest pain. 
Results: The two groups had similar clinical characteristirzs and risk factors for CAD. 
Patients with STSE had a higher incidence of the C/C-174 polymorphwn compared with 
NSTSE patients, who had a higher incidence of the G/G-174 polymorphism. 
In multivariable analysis, independent markers of STSE group were the IL6 polymor- 
phism (O&5.4, 95% Cl 1.6-16.2, p=O.O03) and age (OR=0.91. 95% Cl 0.64-0.97, 
p=O.OOS). 
Conclusion: The genotypic polymorphism G/C-l74 of IL-6 gene may be related to the 
type of ACS (STSE or NSTSE). This association may be due to higher IL-6 production !n 
patients with the C allele in the IL-6 gene. 
